131 related articles for article (PubMed ID: 2074058)
21. [Clinical effects of human fibroblast interferon on malignant tumors].
Ezaki K; Okabe K; Inagaki J; Horikoshi N; Inoue K; Aiba K; Domyo M; Nagata T; Ogawa M
Gan To Kagaku Ryoho; 1982 Jan; 9(1):31-7. PubMed ID: 7184362
[TBL] [Abstract][Full Text] [Related]
22. Recent publications in hematological oncology.
Hematol Oncol; 2007 Sep; 25(3):148-55. PubMed ID: 17957827
[No Abstract] [Full Text] [Related]
23. [Treatment of hematologic diseases with alpha interferon].
Castaigne S
Bull Cancer; 1988; 75(9):859-62. PubMed ID: 3207895
[TBL] [Abstract][Full Text] [Related]
24. Alpha-interferon in myelodysplasia.
Galvani DW; Cawley JC; Nethersell A; Bottomley JM
Br J Haematol; 1987 May; 66(1):145-6. PubMed ID: 3593652
[No Abstract] [Full Text] [Related]
25. Disappearance of trisomy 8 after alpha-2 interferon in a patient with myelodysplastic syndrome.
Blok WL; Lowenberg B; Sizoo W
N Engl J Med; 1988 Mar; 318(12):787-8. PubMed ID: 3347233
[No Abstract] [Full Text] [Related]
26. Urinary enzyme excretion during treatment of malignancies with human recombinant alpha-2 interferon.
Metz-Kurschel U; Kurschel E; Niederle N; Scheulen ME; Graben N
Nephrol Dial Transplant; 1987; 2(6):515-9. PubMed ID: 2894618
[No Abstract] [Full Text] [Related]
27. Interferon in the treatment of multiple myeloma and non Hodgkins lymphoma.
Smruti BK; Nair R; Gopal R
J Assoc Physicians India; 1995; Suppl 3():33-7. PubMed ID: 8773120
[No Abstract] [Full Text] [Related]
28. Alpha interferon in myelodysplasia.
Galvani DW
Haematol Blood Transfus; 1989; 32():139-40. PubMed ID: 2625240
[No Abstract] [Full Text] [Related]
29. [Alpha interferon and lymphoid hemopathies].
Flandrin G
Ann Med Interne (Paris); 1989; 139(8):530-3. PubMed ID: 2729810
[No Abstract] [Full Text] [Related]
30. [Bone marrow transplantation--rapid development towards new indications].
Gahrton G; Ringdén O; Robert KH
Lakartidningen; 1988 Mar; 85(9):689-91, 695. PubMed ID: 3280928
[No Abstract] [Full Text] [Related]
31. Biological molecules in the treatment of hematological disorders.
Kurzrock R; Talpaz M; Gutterman U
Sangre (Barc); 1989 Feb; 34(1):53-8. PubMed ID: 2469130
[No Abstract] [Full Text] [Related]
32. Update on haematologic malignancy.
Jacobs P
Cent Afr J Med; 1986 Apr; 32(4):100-6. PubMed ID: 3791396
[No Abstract] [Full Text] [Related]
33. [Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)].
Ohno R; Kodera Y; Ogura M; Murase T; Emi N; Okumura M; Morishita Y; Nagura E; Minami S; Morishima Y
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2531-6. PubMed ID: 6594973
[TBL] [Abstract][Full Text] [Related]
34. Recombinant alpha interferons 1986: a review.
Lindquist DL; Burns CP
Iowa Med; 1987 Jan; 77(1):32, 34, 36. PubMed ID: 3818250
[No Abstract] [Full Text] [Related]
35. Innovative treatment strategies for non-Hodgkin's lymphoma and multiple myeloma.
Borden EC
Semin Oncol; 1994 Dec; 21(6 Suppl 14):14-22. PubMed ID: 7992095
[TBL] [Abstract][Full Text] [Related]
36. [Interferon (IFN) in multiple myeloma and non-Hodgkin's lymphoma].
Gola A
Acta Haematol Pol; 1994; 25(2 Suppl 1):136-41. PubMed ID: 7520658
[TBL] [Abstract][Full Text] [Related]
37. [Interferon therapy in hematologic neoplasms].
Schwarzinger I; Bettelheim P; Lechner K
Wien Klin Wochenschr; 1988 Aug; 100(15):497-504. PubMed ID: 2459854
[TBL] [Abstract][Full Text] [Related]
38. Clinical uses for interferon in the treatment of cancer. A critical review.
Ringenberg QS; Patterson WP
Mo Med; 1988 Jan; 85(1):21-6. PubMed ID: 3277031
[No Abstract] [Full Text] [Related]
39. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
40. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies].
Gan To Kagaku Ryoho; 1985 Apr; 12(4):928-35. PubMed ID: 3885864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
